Mice with liver-specific TRPC3 silencing manifested mild fatty liver and exacerbated liver pathologies of ALD upon chronic alcohol consumption, whereas genetic replenishment of hepatic TRPC3 ameliorated ALD development. The gene discussed is TRPC3; the disease is Hepatic steatosis.